A Study of Improvement of Left Ventricle Ejection Fraction in Heart Failure Patients with Reduced Ejection Fraction with Coronary Artery Diseases after Revascularization by Percutaneous Coronary Intervention (PCI)

Main Article Content

Mostafa Hamed Mostafa Elbahnasy
Ibtsam Khairat Ibrahim
Ehab Abdel Latef El Gendy
Ehab Abdel Wahab Hamdy

Abstract

Background: Left ventricular dysfunction is the single strongest predictor of mortality and one of the most frequent and deadly complication following coronary artery diseases.

Aim: This   work   aims   to   study   and  explore  the  left  ventricle  ejection  fraction  improvement  after revascularization  with percutaneous coronary intervention (PCI) and the predictive factors for left ventricle ejection fraction improvement.

Methods: One hundred patients with ischemic (HFrEF) who had complete revascularization with percutaneous coronary intervention (PCI), had survived at least 90 days and had undergone echocardiography review. The study duration was 1 year from April 2019 to May 2020.

Result: We focused on a group of the common possible predictive factors affecting left ventricular improvement. Gender (male), CKD, DM, number of affected vessel(single vessel disease), CTO lesion, heart rate, ECG findings, presence of anginal pain, presence of dyspnea , usage of medications ( ACEI and Clopidogrel),hyper urecemia and the time between presentation of complaints and PCI were correlated with improvement of left ventricular function after revascularization by PCI.

Conclusion: Time between appearance of symptoms and PCI was found to be independent predictor of LV EF improvement after revascularization. Other predictors were Male gender, DM, CKD, normal ECG finding ,absence of hyper urecemia, slower heart rate ,presence of chest pain and dyspnea , absence of CTO lesion , single vessel affection and administration of ACEI and Clopidogrel.

Keywords:
Heart failure, ischemia, ejection fraction, revascularization, PCI.

Article Details

How to Cite
Elbahnasy, M. H. M., Ibrahim, I. K., Gendy, E. A. L. E., & Hamdy, E. A. W. (2021). A Study of Improvement of Left Ventricle Ejection Fraction in Heart Failure Patients with Reduced Ejection Fraction with Coronary Artery Diseases after Revascularization by Percutaneous Coronary Intervention (PCI). Cardiology and Angiology: An International Journal, 10(1), 33-40. https://doi.org/10.9734/ca/2021/v10i130161
Section
Original Research Article

References

Brooks GC, Lee BK, Rao R, et al. Predicting persistent left ventricular dysfunction following myocardialinfarction. J Am Coll Cardiol. 2016;67(10):1186–96.

Butler J, Fonarow GC, Zile MR, et al. Developing therapies for heart failure with preserved ejection fraction: current state and future directions. JACC Heart Fail. 2014;2(2):97-112.

DeVore AD, Velazquez EJ. Rethinking Revascularization in Left Ventricular Systolic Dysfunction. Circ Heart Fail. 2017;10(1):e003770.

Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC [published correction appears in Eur Heart J. 2016 Dec 30. Eur Heart J. 2016;37(27):2129-2200.

Rossi JS, Flaherty JD, Fonarow GC, et al. Influence of coronary artery disease and coronary revascularization status on outcomes in patients with acute heart failure syndromes: a report from OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure). Eur J Heart Fail. 2008;10(12):1215-1223.

Peng D, Liu, J-h. Improvement of LVEF in patients with HFrEF with coronary heart disease after revascularization—A real-world study. J Interv Cardiol. 2018;31: 731– 736.

Wilcox JE, Fonarow GC, Yancy CW, et al. Factors associated with improvement in ejection fraction in clinical practice among patients with heart failure: Findings from IMPROVE HF. American Heart Journal. 2012;163(1):49-56.e2.

Bundhun PK, Wu, et al. Impact of modifiable cardiovascular risk factors on mortality after percutaneous coronary intervention: A systematic review and meta-analysis of 100 studies. Medicine. 2015; 94(50), e2313.

Afzal A, Nisar et al. Impact of renal dysfunction on periprocedural outcomes in patients with ischemic cardiomyopathy undergoing elective Percutaneous Coronary Intervention (PCI). Journal of Cardiac Failure. 2019;25(8):S127–S128.

Bax JJ, Schinkel A et al. Early versus delayed revascularization in patients with ischemic cardiomyopathy and substantial viability: Impact on outcome. Circulation. 2003;108(1)II39–II42.

Joyce E, Hoogslag GE, Leong DP, et al. Association between discharge heart rate and left ventricular adverse remodelling in ST segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention. Heart 2013;99(8):556–61. Chuang LH, Gumbs P, van Hout B, Agnelli G, Kroep S, Monreal M, et al. Health-related quality of life and mortality in patients with pulmonary embolism: A prospective cohort study in seven European countries. Qual Life Res. 2019; 28(8):2111-2124.

Mashayekhi, K, Nührenberg, et al. A randomized trial to assess regional left ventricular function after stent implantation in chronic total occlusion: The REVASC trial. JACC: Cardiovascular Interventions. 2018;11(19):1982–1991.

Galassi AR, Boukhris et al. Percutaneous coronary intervention of chronic total occlusions in patients with low left ventricular ejection fraction. JACC. Cardiovascular interventions. 2017;10(21): 2158–2170.

Traupe Gloekler, Seiler, et al. Assessment of the human coronary collateral circulation. Circulation. 2010;122(12);1210–1220.

Van Dongen I, Elias M, et al. Impact of collateralisation to a concomitant chronic total occlusion in patients with ST-elevation myocardial infarction: a subanalysis of the EXPLORE randomised controlled trial. Open heart. 2018; 5(2), e000810.

Surber R, Schwarz et al. Resting 12-lead electrocardiogram as a reliable predictor of functional recovery after recanalization of chronic total coronary occlusions. Clinical cardiology. 2005; 28(6):293–297.

Schinkel AF, Poldermans D, et al. Assessment of myocardial viability in patients with heart failure. Journal of nuclear medicine: Official publication, Society of Nuclear Medicine. 2017;48(7):1135–1146.

Samy M, El Awady, et al. Echocardiographic assessment of left ventricular function recovery post percutaneous coronary intervention of chronic total occlusions in patients with low and mid-range left ventricular ejection fractions. Echocardiography (Mount Kisco, N.Y). 2020;37(2):239–246.

Holper EM, Blair J, et al. The impact of ejection fraction on outcomes after percutaneous coronary intervention in patients with congestive heart failure: An analysis of the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry and Dynamic Registry. American heart journal. 2006;151(1):69–75.

Hashemi SR, Motamedi et al. Evaluation of the effect of elective percutaneous coronary intervention as a treatment method on the left ventricular diastolic dysfunction in patients with coronary artery disease. The journal of Tehran Heart Center. 2010; 5(4):194–198.

Mandal AK, Chowdhury AHK, et al. Echocardiographic evaluation of left ventricular diastolic function after percutaneous coronary intervention in patients with coronary artery disease. Cardiovascular Journal. 2012;4(2):127-131.